2013
DOI: 10.3762/bjoc.9.281
|View full text |Cite
|
Sign up to set email alerts
|

Biosynthesis of rare hexoses using microorganisms and related enzymes

Abstract: SummaryRare sugars, referred to as monosaccharides and their derivatives that rarely exist in nature, can be applied in many areas ranging from foodstuffs to pharmaceutical and nutrition industry, or as starting materials for various natural products and drug candidates. Unfortunately, an important factor restricting the utilization of rare sugars is their limited availability, resulting from limited synthetic methods. Nowadays, microbial and enzymatic transformations have become a very powerful tool in this f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
57
0
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 74 publications
(59 citation statements)
references
References 93 publications
0
57
0
2
Order By: Relevance
“…Rare sugars, which are defined by the International Society of Rare Sugars (ISIR) as the monosaccharides and their derivatives rarely existing in nature, are attracting increasing attention of researchers, due to their great potential in food, medical, and chemical fields [1,2]. Based on decades of scientific efforts, the research groups (especially Ken Izumori group) in the Kagawa University Rare Sugar Research Center have created a cyclic bioconversion strategy, named Izumoring, by which all monosaccharides become interrelated by means of several groups of biocatalysts [3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…Rare sugars, which are defined by the International Society of Rare Sugars (ISIR) as the monosaccharides and their derivatives rarely existing in nature, are attracting increasing attention of researchers, due to their great potential in food, medical, and chemical fields [1,2]. Based on decades of scientific efforts, the research groups (especially Ken Izumori group) in the Kagawa University Rare Sugar Research Center have created a cyclic bioconversion strategy, named Izumoring, by which all monosaccharides become interrelated by means of several groups of biocatalysts [3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…The unabsorbed tagatose is fermented in the colon, where it acts as soluble fibre [15,16]. Besides, it does not promote tooth decay and it only provides 1.5 kcal/g to diet [17]. Tagatose was generally recognized as safe (GRAS) in 2010 [18].…”
Section: Introductionmentioning
confidence: 99%
“…Contrastingly and as achieved in our previous study and literature, L-fructose was exclusively produced when RhaD E. coli accepts L-glyceraldehyde as the acceptor. [3][4][5] Since RhaD T.mari is from a thermophilic source, we are curious to know the temperature effect on its activity. Thus, aldol reactions catalyzed by RhaD T.mari without Nus tag using DHAP and D-glyceraldehyde as substrates were carried out at a 8 series of temperature.…”
mentioning
confidence: 99%
“…Recent progress of the biosynthesis of rare hexoses including ketohexoses, aldohexoses, and sugar alcohols was summarized in our recent review. 4 Our group has been focusing on the in vitro enzymatic synthesis of rare sugars and we mainly used DHAP-dependent aldolases because they have been proven remarkably useful due to their predictable stereochemical outcome and thus widely investigated among the aldolase families. [5][6][7] For example, L-rhamnulose-1-phosphate aldolase (RhaD) is a commonly used enzyme that catalyzes the reversible cleavage of L-rhamnulose-1-phosphate to dihydroxyacetone phosphate (DHAP) and L-lactaldehyde (Scheme 1).…”
mentioning
confidence: 99%